These success, along with a previous report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two guidance the strategy of targeting ACKR3 as a unique method to modulate the opioid technique, which could open new therapeutic avenues for opioid-linked Pr